The Oxford-Harrington Rare Disease Scholar Award seeks novel approaches to treat rare diseases. Proposals of interest include discoveries demonstrating rigorous science, innovation, and potential for clinical impact. Projects with novel, validated targets are of particular interest. The current focus areas of the OHC are neurological disorders, developmental and metabolic disorders, and rare cancers, but we welcome applications directed to other rare, genetic indications with a high unmet need. Any therapeutic modality will be considered.
Key considerations also include:
- Novel approaches to treat rare diseases (either European or US definition of a rare disease can be applied. Ultra-rare diseases will also be considered)
- Potential to be developed into a commercial program
- Strong intellectual property (IP) or protection strategy
For more information, including eligibility requirements, please visit their website.
Deadline: March 10, 2025